期刊文献+

EB病毒膜潜伏蛋白LMP1和基质金属蛋白酶MMP9表达与鼻咽癌转移的关系 被引量:2

Association of LMP1 and MMP9 with metastasis of nasopharyngeal carcinoma
暂未订购
导出
摘要 目的探讨EB病毒膜潜伏蛋白LMP1和基质金属蛋白酶MMP9在鼻咽癌组织表达的意义。方法采用免疫组织化学法对40例鼻咽癌组织进行标记及分析。结果鼻咽癌淋巴结转移组LMP1和MMP9阳性表达率明显高于无淋巴结转移组,二者阳性表达呈明显相关。结论 LMP1和MMP9的表达与鼻咽癌的浸润及转移密切相关,LMP1介导MMP9在鼻咽癌细胞扩散和转移起重要作用。 Objective To evaluate the significance about the expression of latent membrane protein 1(LMP1)and matrix metalloproteinase 9(MMP9)in the nasopharyngeal carcinoma(NPC).Methods Forty cases of NPC were studied by using monoclonal antibody to LMP1 and MMP9 with immunohistochemical method.Results The positive rates of LMP1 and MMP9 were higer in NPC with cervical lymph node involvement than those without cervical lymph node involvement.The expression of MMP9 showed a significant positive correlation with the expression of LMP1.Conclusion There are significant correlations between LMP1 and MMP9 and the invasion and metastasis of NPC.The results suggest that the induction of LMP1 on MMP9 contributes to the metastatic potential of NPC.
出处 《福建医药杂志》 CAS 2010年第5期76-79,共4页 Fujian Medical Journal
关键词 膜潜伏蛋白 基质金属蛋白酶 鼻咽肿瘤 肿瘤转移 latent membrane protein matrix metalloproteinase nasopharyngeal carcinoma neoplasm metastasis
  • 相关文献

同被引文献24

  • 1韦正波,黄光武,温文胜,张哲,谢莹.鼻咽癌患者外周血树突状细胞体外扩增及生物学特性的研究[J].临床耳鼻咽喉科杂志,2005,19(23):1068-1071. 被引量:4
  • 2匡志鹏,梁安民.CIK细胞联合树突状细胞治疗恶性肿瘤的研究进展[J].现代肿瘤医学,2006,14(2):240-242. 被引量:22
  • 3李高峰,陈龙华.ATM在肿瘤放射增敏治疗中的研究进展[J].重庆医学,2007,36(21):2224-2226. 被引量:3
  • 4Yashin DV,Sashchenko LP,Kabanova OD,et al. The CD8^+ population of LAK cells can lyse both HLA-positive and HLA-negative cancer cell lines[J]. Dokl Biol Sci, 2009,426 : 296-297.
  • 5Sebastian M,Passlick B, Friccius-Quecke H,et al. Treat- ment of non-small cell lung cancer patients with the tri- functional monoclonal antibody catumaxomab (anti-Ep- CAM x anti-CD3):a phase I study[J]. Cancer Immunol Immunother, 2007,56(10) : 1637-1644.
  • 6Yao Y,Chen L,Wei W,et al. Tumor cell-derived exo- some-targeted dendritic cells stimulate stronger CD8^+ CTL responses and antitumor immunities[J]. Biochem Biophys Res Commun, 2013,436 ( 1 ) : 60-65.
  • 7Haque T,Wilkie GM,Jones MM,et al. Allogeneic cyto- toxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease:results of a phase 2 multi- center clinical trial[J]. Blood, 2007,110(4) : 1123-1131.
  • 8Icheva V, Kayser S,Wolff D,et al. Adoptive transfer of epstein-barr virus (EBV) nuclear antigen 1-specific T cells as treatment for EBV reactivation and lymphoprolif- erative disorders after allogeneic stem-cell transplantation [J]. J Clin Oncol,2013,31 (1) : 39-48.
  • 9Basso S,Zecca M,Merli P,et al. T cell therapy for na- sopharyngeal carcinoma [ J ]. J Cancer, 2011,2 : 341-346.
  • 10Pan J,Zhang Q,Zhou J,et al. Recombinant adeno-associ- ated virus encoding Epstein-Barr virus latent membrane proteins fused with heat shock protein as a potential vac- cine for nasopharyngeal carcinoma[J]. Mol Cancer Ther, 2009,8(9) :2754-2761.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部